Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.

A new study found that infants receiving maternal Respiratory Syncytial Virus (RSV) vaccination or Nirsevimab after birth had ...

RSV is the most common reason why babies end up in the hospital in their first year. A new study finds a vaccine for expectant mothers is more effective at protecting babies than previously shown.

Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, ...

U.S. health officials have asked doctors to prioritize which infants get the new RSV shot, just as cases of the respiratory disease begin to rise with the onset of cold and flu season. Due to a ...

A study of nursing home residents demonstrated that vaccination against respiratory syncytial virus reduced their risk for illness, although protection waned over time for some. Researchers measured ...

Giving the respiratory syncytial virus (RSV) vaccine to pregnant women provides 81.3% protection to newborn infants, ...

The Food and Drug Administration on Wednesday approved the world’s first RSV vaccine: a shot for adults ages 60 and up, made by pharmaceutical giant GSK. The milestone was decades in the making.

The federal government program that already offers free jabs during pregnancy will be expanded to include over-75s, amid ...

Babies whose mothers were vaccinated against respiratory syncytial virus earlier in pregnancy had stronger protection against ...

A federal court order has halted the work of a key U.S. vaccine advisory panel, disrupting the system that guides COVID-19, ...

The Albanese Government is introducing free Respiratory Syncytial Virus (RSV) vaccinations for older Australians to ensure they are protected from the ...